Loading...
Home2018-09-22T17:07:42+00:00

The Impact of Ascites

Americans suffering from ascites due to liver cirrhosis

The prognosis is not good, but what is worse is the feeling of helplessness because there is no adequate treatment available beyond the initial diuretic pills and draining by large bore needle.

The current standard of care has generally poor outcomes. Unfortunately, patients often have nothing hopeful to look forward to other than the possibility of a liver transplant.

Disease Target
100,000 Americans estimated
to be suffering from ascites
due to liver cirrhosis
20,000 estimated patients
who do not respond to
ascites treatment
326,000 approximate
hospitalizations annually
for ascites

An Innovative Approach to Ascites

We are targeting the disease pathway of ascites. Taking a new look at the mechanistic source, we are engineering a solution that is a combination of existing technology and innovative application.

We are currently conducting a Phase 2a clinical trial which, if successful, could yield a breakthrough treatment for this life-threatening condition.

Clinical Program

Working on a solution to such a devastating condition is what keeps us going everyday.

Chief Scientific Officer, BioVie Inc.

Efficiency and alignment are paramount in advancing toward commercialization.

Chief Operating Officer, BioVie Inc.

Our Team

Our leadership team is made up of veteran executives who have both rich and deep experience in our industry, our science, and our operations. See our team.

Press Releases

Read more Press Releases

Pioneering the Treatment of Ascites

Bringing hope to patients suffering from ascites due to cirrhosis,

and their physicians who need better treatment options.

This website uses cookies and third party services. Settings Ok

Cookies

This site uses cookies and third party services

Third party embeds

This site allows third-party services to track activity on this site